-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$65.33301.54% Upside
Arcturus Therapeutics Holdings Inc. Frequently Asked Questions
-
What analysts cover Arcturus Therapeutics Holdings Inc.?
Arcturus Therapeutics Holdings Inc. has been rated by research analysts at Canaccord Genuity, H.C. Wainwright, Piper Sandler, Laidlaw, Barclays, Goldman Sachs in the past 90 days.